Cilastatin


CAS No. : 82009-34-5

(Synonyms: MK0791)

82009-34-5
Price and Availability of CAS No. : 82009-34-5
Size Price Stock
5mg $38 In-stock
10mg $60 In-stock
50mg $108 In-stock
100mg $168 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-A0166
M.Wt: 358.45
Formula: C16H26N2O5S
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic);H2O : 5 mg/mL (ultrasonic;warming;heat to 60°C);1M NaOH : 100 mg/mL (ultrasonic;adjust pH to 12 with NaOH)
Introduction of 82009-34-5 :

Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin is an antibacterial adjunct[1][2][3]. IC50 & Target:IC50: 0.1 μM (Renal dehydropeptidase I); 178 μM (Bacterial metallob-lactamase enzyme CphA)[1] In Vitro:Cilastatin (200 μg/mL; 24 hours; RPTECs) treatment protects against Vancomycin-induced proximal tubule apoptosis and increases cell viability, without compromising the antimicrobial effect of Vancomycin[2]. In Vivo:In a mouse model (female mice, strain CD-1, 20 g) of systemic infection, Imipenem plus Cilastatin can protect mice from S. aureus, E. coli, and P. aeruginosa infection[3].

Your information is safe with us.